TY - JOUR
T1 - Abstract P6-17-01: Adjuvant treatment with zoledronic acid (ZOL) in stage II/III breast cancer. The AZURE trial (BIG 01/04) 10 year follow-up
JO - Cancer Research
UR - http://dx.doi.org/10.1158/1538-7445.sabcs16-p6-17-01
PY - 2017/02/15
AU - Coleman R
AU - Collinson M
AU - Bell R
AU - Marshall H
AU - Dodwell D
AU - Keane M
AU - Gil M
AU - Gregory W
AU - Cameron D
ED -
DO - DOI: 10.1158/1538-7445.sabcs16-p6-17-01
PB - American Association for Cancer Research (AACR)
VL - 77
IS - 4_Supplement
Y2 - 2025/07/31
ER -